Skip to main content
Aurora Cannabis Inc. (ACB)
NASDAQ: ACB · IEX Real-Time Price · USD
5.90
+0.11 (1.90%)
At close: Jul 26, 2024, 4:00 PM
5.91
+0.01 (0.17%)
After-hours: Jul 26, 2024, 7:10 PM EDT

Aurora Cannabis Revenue

In the fiscal year ending March 31, 2024, Aurora Cannabis had annual revenue of 270.28M CAD with 20.77% growth. Aurora Cannabis had revenue of 67.41M in the quarter ending March 31, 2024, with 6.11% growth.

Revenue (ttm)
270.28M CAD
Revenue Growth
+20.77%
P/S Ratio
1.27
Revenue / Employee
251,893 CAD
Employees
1,073
Market Cap
321.84M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024270.28M46.48M20.77%
Mar 31, 2023223.80M2.47M1.11%
Jun 30, 2022221.34M-23.91M-9.75%
Jun 30, 2021245.25M-23.45M-8.73%
Jun 30, 2020268.70M23.17M9.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OraSure Technologies 304.64M
Amarin Corporation 277.46M
Zynex 188.68M
Sutro Biopharma 154.07M
Spok Holdings 140.75M
Pulmonx 72.99M
Enanta Pharmaceuticals 72.88M
Adaptimmune Therapeutics 18.36M
Revenue Rankings

ACB News

More News